Eli Lilly | Kredi Sermaye



Loan Capital Değişiklik Tarih
AbbVie USD 60.34B 1.83B 2024-12
Abbott USD 12.62B 200M 2024-12
ALKERMES USD 0 285.82M 2024-12
Amgen USD 56.55B 305M 2024-12
AstraZeneca USD 27.73B 2.29B 2024-12
Baxter International USD 10.37B 63M 2024-12
Biogen USD 4.55B 1.4M 2024-12
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Drreddys Laboratories INR 7.58B 218M 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 14.64B 1.39B 2024-12
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Indivior 270M 2M 2024-09
J&J USD 30.65B 638M 2024-12
Medtronic USD 23.99B 622M 2025-01
Merck USD 34.46B 520M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 22.93B 2.41B 2024-12
Novartis USD 22.93B 2.41B 2024-12
Novo Nordisk 51.45B 156M 2024-09
Perrigo USD 3.58B 730.9M 2024-12
Pfizer USD 57.4B 597M 2024-12
Prestige Brands USD 996.05M 55.67M 2024-12
Regeneron Pharmaceuticals USD 2.7B 720.4M 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 12.5B 1.84B 2024-06
Sanofi 12.5B 1.84B 2024-06
United Therapeutics USD 0 0 2024-12
Zoetis USD 5.22B 1.35B 2024-12



Eli Lilly Kredi Sermaye - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Mar 2025.